Preoperative Treatment of Locally Advanced Rectal CancerDeborah Schrag, Harvey J. Mamon, Hagen F. Kennecke et al.|New England Journal of Medicine|2023Cited by 440
Patient-Reported Outcomes During and After Treatment for Locally Advanced Rectal Cancer in the PROSPECT Trial (Alliance N1048)Ethan Basch, Deborah Schrag, Amylou C. Dueck et al.|Journal of Clinical Oncology|2023Cited by 136
An International Collaborative Standardizing a Comprehensive Patient-Centered Outcomes Measurement Set for Colorectal CancerJessica A. Zerillo, Rob A.�E.�M. Tollenaar, Maartje G. Schouwenburg et al.|JAMA Oncology|2017Cited by 134
A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic CarcinomaUmair Mahmood, Jonathan D. Schoenfeld, Andrew Bang et al.|International Journal of Radiation Oncology*Biology*Physics|2020Cited by 111
PROSPECT: A randomized phase III trial of neoadjuvant chemoradiation versus neoadjuvant FOLFOX chemotherapy with selective use of chemoradiation, followed by total mesorectal excision (TME) for treatment of locally advanced rectal cancer (LARC) (Alliance N1048).Deborah Schrag, Harvey J. Mamon, Qian Shi et al.|Journal of Clinical Oncology|2023Cited by 18